VKH
GCVRZ

Virtu KCG Holdings’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Virtu KCG Holdings’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$9K Buy
+22,891
New +$9.34K ﹤0.01% 2787
2017
Q1 		– Sell
-19,188
Closed -$7K – 4259
2016
Q4 		$7K Buy
+19,188
New +$6.5K ﹤0.01% 3319

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Virtu KCG Holdings's GCVRZ Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Sanofi Contingent Value Rights (GCVRZ) in Q2 2017: 22,891 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #2787 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in GCVRZ as recently as Q4 2016.

Virtu KCG Holdings first reported a position in GCVRZ in Q4 2016 and has held it in 2 quarters since. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2017.

  • Virtu KCG Holdings held 22,891 shares of Sanofi Contingent Value Rights worth $9K as of Q2 2017.
  • Sanofi Contingent Value Rights was a new Virtu KCG Holdings position in Q2 2017.
  • Sanofi Contingent Value Rights made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2787 holding.
  • Virtu KCG Holdings first reported a position in Sanofi Contingent Value Rights in Q4 2016 and has held it in 2 quarters since.
  • 115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.